MEDICINES CO's ticker is and the CUSIP is 584688AG0. A total of 45 filers reported holding MEDICINES CO in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $3,686,000 | -17.0% | 4,935,000 | +1.5% | 0.13% | +2.4% |
Q3 2018 | $4,441,000 | +13.5% | 4,860,000 | +22.1% | 0.13% | +12.5% |
Q2 2018 | $3,914,000 | -3.0% | 3,980,000 | -5.5% | 0.11% | -4.3% |
Q1 2018 | $4,033,000 | +3.7% | 4,210,000 | 0.0% | 0.12% | +4.5% |
Q4 2017 | $3,890,000 | -12.2% | 4,210,000 | 0.0% | 0.11% | -11.1% |
Q3 2017 | $4,433,000 | +90.7% | 4,210,000 | +90.5% | 0.13% | +93.8% |
Q2 2017 | $2,324,000 | – | 2,210,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Man Investments (CH) AG | 3,000,000 | $3,159,000 | 2.70% |
ZAZOVE ASSOCIATES LLC | 22,990,000 | $24,168,000 | 1.24% |
CAPSTONE INVESTMENT ADVISORS, LLC | 24,215,000 | $25,577,000 | 0.90% |
PFM Health Sciences, LP | 29,442,000 | $31,098,000 | 0.61% |
WOLVERINE ASSET MANAGEMENT LLC | 47,500,000 | $49,903,000 | 0.55% |
LINDEN ADVISORS LP | 14,665,000 | $15,426,000 | 0.55% |
ARISTEIA CAPITAL, L.L.C. | 12,000,000 | $12,599,000 | 0.49% |
Partner Investment Management, L.P. | 483,000 | $510,000 | 0.48% |
SSI INVESTMENT MANAGEMENT LLC | 4,518,000 | $4,748,000 | 0.40% |
ADVENT CAPITAL MANAGEMENT /DE/ | 12,886,000 | $13,540,000 | 0.26% |